Select Page

News Releases

May 13-15th, 2022

Come visit SonoMotion at the American Urological Association conference in New Orleans on May 13-15 (Booth #1909).

May 5th, 2022

First of its kind procedure successfully conducted by SonoMotion and Vancouver Aquarium on Hermes, a harbor seal suffering from kidney stones (press release and video) .

April, 6th, 2022

SonoMotion completes initial close of $11.5 Million Series-C funding round co-led by UWH LLC and Advance MedTech Holdings Pte. Ltd.

March 22nd, 2022

Journal of Urology publishes University of Washington First-In-Human clinical trial results from the first 19 subjects treated by BWL.  Article selected for the cover of the May edition (press release)

January 24th, 2022

SonoMotion treats its 40th subject in the Break Wave Feasibility First-In-Human clinical trial.

October 1st, 2021

SonoMotion secures a $400,000 Commercial Readiness Program (CRP) SBIR grant from the NIH.

November 7th, 2019

SonoMotion closes $10M Series-B round co-led by Advance MedTech Holdings Pte. Ltd., MedVenture Partners Inc and BioVentures. Link to press release.

August 20th, 2019

SonoMotion initiates First-In-Human clinical trial of its Break WaveTM stone fragmentation system

May 1st, 2019

SonoMotion secures a $3M SBIR Phase IIB grant from the NIH in support of its Break WaveTM First-In-Human clinical trial. Planned sites include UW, UBC, UCSD, Cleveland Clinic and Chesapeake Urology.

March 28th, 2019

GE Healthcare and SonoMotion sign a second co-development agreement and expand their strategic relationship with an updated OEM agreement.

March 26th, 2019

SonoMotion receives Health Canada ITA approval to initiate its Break WaveTM First-In-Human clinical trial in Canada.

December 14th, 2018

SonoMotion receives FDA IDE approval to initiate its Break WaveTM First-In-Human clinical trial in the United States.

October 31st, 2017

GE Healthcare and SonoMotion establish a strategic partnership and sign a definitive OEM agreement and co-development agreement.

August 1st, 2017

SonoMotion receives a $1.0M SBIR Commercial Readiness Program grant from the NIH for the development of Stone ClearTM.

April 7th, 2017

SonoMotion closes on a $4.6M Series-A round led by MedVenture Partners Inc. and with a significant participation by Bioventures Investors.

May 1st, 2016

SonoMotion secures a $1.75M SBIR FastTrack grant from the NIH for the development of Break WaveTM.

April 1st, 2016

SonoMotion receives a $350,000 grant from NASA and NSBRI to accelerate development of Break WaveTM.

December 2nd, 2015

SonoMotion wins Runner-Up and $50,000 in the prestigious primeUC life science startup competition organized by the University of California and Johnson & Johnson.

September 7th, 2015

Dr. Doug Corl joins SonoMotion as its Chief Technology Officer bringing over 35 years of experience in developing commercial ultrasound-based medical devices.

August 1st, 2015

 SonoMotion secures a $1.75M non-dilutive SBIR grant funding from the NIH for the development of Stone ClearTM

Jan 11th, 2015

SonoMotion reaches agreement with the University of Washington for exclusive license to an extensive IP portfolio related to Break WaveTM and Stone ClearTM.

May 19th, 2015

 Positive First-In-Man Stone ClearTM clinical trial results presented at the American Urological Association (AUA) meeting in New Orleans.

October 24th, 2014

SonoMotion brings onboard Dr. Oren Levy as its Chief Executive Officer and Chairman of the Board.

May 5th, 2022

First of its kind procedure successfully conducted by SonoMotion and Vancouver Aquarium on Hermes, a harbor seal suffering from kidney stones (press release and video) .

May 13-15th, 2022

Come visit SonoMotion at the American Urological Association conference in New Orleans on May 13-15 (Booth #1909).